HighTower Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
HighTower Advisors's ABBV Position: Q2 2026 in Review
HighTower Advisors increased its AbbVie (ABBV) stake by 19% in Q2 2026, buying an estimated $66.5M and bringing the position to 1,967,343 shares worth $495M. The position accounts for 0.48% of the portfolio, ranked #35.
HighTower Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- HighTower Advisors held 1,967,343 shares of AbbVie worth $495M as of Q2 2026.
- HighTower Advisors bought 309,319 AbbVie shares in Q2 2026, an estimated $66.5M.
- AbbVie made up 0.48% of HighTower Advisors's portfolio in Q2 2026, its #35 holding.
- HighTower Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.